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Do family physicians’ records fit guideline diagnosed
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Albers M, Schermer T, Molema J, Kloek C, Akkermans R, Heijdra Y and van Weel C. Do family
physicians’ records fit guideline diagnosed COPD? Family Practice 2009; 26: 81–87.
Background. In family practice, chronic obstructive pulmonary disease (COPD) is usually not
diagnosed until clinically apparent and of moderately advanced severity.
Objective. To analyse the diagnostic process from early development onwards and to assess
the current state of underpresentation and underdiagnosis of COPD and asthma in primary care
in the Netherlands.
Methods. The population-based study sample consisted of formerly undiagnosed subjects
(n = 532) from family practice. Family physicians’ (FPs) chronic respiratory disease diagnoses
(as recorded over 10 years in their patient records) were compared to a cross-sectional but ex-
tensive diagnostic assessment by a chest physician. Logistic regression modelling was used
for a retrospective analysis on the relation between respiratory symptoms, practice visit rate
and FPs’ diagnosis of COPD.
Results. After 10 years, the chest physician diagnosed 26% of subjects as COPD and 16% as (late-
onset) asthma. Underpresentation of these patients in family practice was 46%, whereas under-
diagnosis occurred in 37% of patients. A chest physician diagnosis of COPD was associated with
the presence of chronic cough [odds ratio (OR) = 2.3, 95% confidence interval (CI) 1.1–4.6],
a FP diagnosis of COPD with chronic phlegm (OR = 10.6, 95% CI 1.3–83.6). Repeated practice visits
(OR = 1.8) and presence of wheeze and breathlessness (OR = 5.5) appeared to trigger the diagnos-
tic process in family practice.
Conclusions. There is still considerable underpresentation and underdiagnosis of COPD in
family practice. As FPs focus on presented symptoms and as detection increases with the fre-
quency of practice visits, diagnostic guidelines should stress the importance of persistent cough
and phlegm to support timely diagnosis of COPD in family practice.
Keywords. Asthma, COPD, early diagnosis, family medicine, guideline.
Introduction
In primary care, chronic obstructive pulmonary dis-
ease (COPD) and asthma are commonly encountered
health problems. However, prevalence and morbidity
data underestimate the true burden of these diseases.
In particular, COPD is often not diagnosed until it
has developed into a clinically advanced stage.1 As
disease prognosis and therapeutic strategies for COPD
and asthma differ, it is important to distinguish be-
tween these two chronic respiratory conditions.
Distinction may be relatively easy in patients with se-
vere disease or in older patients, but in many cases
the distinction is not so clear as clinical signs and
symptoms show overlap. This is particularly the case
in family practice, where the diagnostic process is pri-
marily based on symptoms and signs presented by the
patient. At this point, objective parameters such as
the presence and degree of airway obstruction, its re-
versibility, diurnal peak flow variability, bronchial hy-
perresponsiveness (BHR) and allergies become
important.2 Although these additional measurements
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usually help to distinguish in the overlapping part of the
spectrum,2–4 they do not always allow a clear-cut differ-
entiation between COPD and asthma.5 Besides the diag-
nostic problems, patients’ presentation of respiratory
symptoms is another cause of underdiagnosis: several
studies have pointed to the fact that patients may well
experience symptoms, but do not always present these
symptoms to their family physician (FP).6,7 There are in-
dications that this underpresentation is at least partly ex-
plained by a lack of perceiving dyspnoea8 or adaptation
to respiratory symptoms9 by patients. To further under-
stand underdiagnosis of COPD, it is important to gain
insight in the process of diagnostic labelling and differ-
entiation by primary care physicians, from early disease
development onwards. Therefore, the main objective of
this study was to investigate the process of diagnosis of
COPD and to assess the current state of underpresenta-
tion and underdiagnosis of patients with COPD in fam-
ily practice.
Methods
Design
In this study, we compared the diagnoses of COPD
and asthma from FPs’ medical records within their
regular patient care, to a single cross-sectional but ex-
tensive diagnostic assessment by a chest physician.
The chest physician’s diagnostic assessment was based
on a standard protocol which included lung function
testing (spirometry, reversibility, static lung volumes
and diffusion capacity), respiratory symptoms and risk
factors for chronic respiratory disease. FPs’ diagnoses
were extracted by standardized medical file review for
the 10 years preceding the chest physicians’ diagnostic
assessment. The medical ethics review board of the
Radboud University Nijmegen Medical Centre ap-
proved the study. All subjects gave written informed
consent.
Study population
Data for this study came from the prospective population-
based Detection, Intervention and Monitoring of COPD
and Asthma (DIMCA) programme.10 In summary, the
DIMCA programme started in 1992 and was originally
designed to investigate the feasibility and effectiveness of
early detection of chronic respiratory disease in family
practice. A random sample from the adult practice popu-
lation (20–70 years) of 10 family practices was divided into
two groups: an intervention group invited for respiratory
screening and a reference group (see Fig. 1). Subjects
with a medical history of COPD, asthma or other chronic
respiratory conditions were excluded. Subjects in the
intervention group took part in a respiratory screening
programme (i.e. lung function testing and a respiratory
questionnaire) to detect undiagnosed COPD or
asthma. Subjects with respiratory symptoms, lung
function below normal range11 or a relevant response
on salbutamol (reversibility) were considered to be at
increased risk (at risk) for developing respiratory mor-
bidity. In a next step, all at-risk subjects were invited
to participate in a 2-year monitoring programme and
participation in inhaled corticosteroid trials12–14. Ref-
erence group subjects were kept unaware of the
screening and monitoring programme (through ran-
domized consent) according to Zelen.15 For the cur-
rent analysis, all subjects who were still in follow-up
10 years after the start of the DIMCA programme
were invited for a reassessment, the results of which
were assessed by a chest physician.
Measurements
All lung function measurements were performed at the
pulmonary function laboratory of the University Lung
Centre Dekkerswald by a certified lung function tech-
nician and included a flow–volume curve, reversibility
testing, static lung volumes (total lung capacity, resid-
ual volume, functional residual capacity) and carbon
monoxide diffusion capacity (DLCO, KCO). All meas-
urements were performed according to the American
Thoracic Society standards.16 European Community
for Coal and Steel reference values17 were used to cal-
culate predicted lung function values. Reversibility
was defined as a 12% change of predicted forced expi-
ratory volume in 1 second (FEV1) and a change of at
least 200 ml in FEV1 after administering 800 lg salbuta-
mol by volume spacer. BHR was assessed with a hista-
mine challenge test (positive at a provocative histamine
concentration < 8 mg/ml18). After lung function testing,
subjects were interviewed on the presence and fre-
quency of respiratory symptoms, allergy, hyperreactiv-
ity of the airways for inhaled trigger factors, personal
or family history of respiratory diseases, occurrence
and frequency of exacerbations, use of respiratory med-
ication and smoking behaviour.
Diagnoses by chest physicians and FPs
Two chest physicians (YH and JM) performed a guide-
line-based diagnostic assessment of the measurements of
all study subjects in order to establish the presence or ab-
sence of chronic respiratory disease. The procedure for
this diagnostic assessment was based on a standardized
protocol of all available diagnostic information regarding
pre- and post-bronchodilator lung function, respiratory
symptoms (cough, phlegm, breathlessness) and smoking
behaviour. The chest physicians used a decision tree
based on international guideline criteria for diagnosing
COPD and asthma. By protocol, any subject who re-
ceived another diagnosis than ‘no COPD or asthma’ was
also presented to the other chest physician and mutually
discussed. As the study aimed to reach a maximal sub-
stantiated diagnosis, the chest physicians could request
additional diagnostic tests (e.g. oral steroid test,
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histamine provocation test, peak expiratory flow moni-
toring, allergy test) when they considered this to be
necessary. Together with the additional diagnostic infor-
mation, the case was returned to the chest physicians
who established a final diagnosis. All subjects were in-
formed about this final diagnosis through their own FP.
FPs’ diagnoses of chronic respiratory disease were
extracted from the medical files in the practices for
the 10 years between the start of the DIMCA pro-
gramme and the chest physicians’ diagnostic assess-
ment. To standardize the file review, and as electronic
ICPC coded information was not available for the first
of these years, the investigator used a checklist that in-
cluded terms and distinctive features for both estab-
lished and suspected respiratory disease.
Analysis
For every study subject, the FPs’ diagnosis as docu-
mented in the subjects’ medical record (if any) was
compared to the chest physicians’ standardized diag-
nostic assessment, in particular regarding the presence
or absence of COPD and asthma. We looked at
the concordance and discordance between the
FP-documented diagnoses and the chest physicians’
diagnostic assessment within subjects to assess under-
presentation and underdiagnosis of COPD and asthma
in family practice. We used logistic regression analysis
to investigate the diagnostic outcome as judged by the
chest physicians in relation to respiratory symptoms at
the time of reassessment and prior respiratory-related
rate of FP visits. Odds ratios (ORs) for respiratory
symptoms (cough, phlegm and wheeze with breath-
lessness) and family practice visit rate were calculated
and adjusted for age, gender and smoking status dur-
ing follow-up. The SAS statistical package (version
V8.2 for Windows) was used for all analyses. Two-
sided P values <0.05 were considered to be statistically
significant.
FIGURE 1 Flow chart of the overall DIMCA programme.10 In the current paper, we focus on the sample of 532 subjects in the final
assessment at Year 10 *12% (n = 239) of subjects were excluded from the initial cohort because respiratory disease had already been
diagnosed by the FP. #Due to refusal, withdrawal (co-morbidity) or loss to follow-up (relocation, death). $At Year 5, the follow-up
cohort was reduced to 1000 subjects, envisaging 400 subjects in the at-risk group, 200 subjects in the group without respiratory
abnormalities and 400 subjects in the reference group. +A total number of 145 at-risk subjects participated in one of the randomized
controlled trials.12–14
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Results
Study population
Ten years after the start of the DIMCA programme,
we reinvited all 985 subjects who had previously been
assessed at Year 5 (Fig. 1). In the group with previous
respiratory abnormalities (n = 384), the response rate
was 76% and the actual participation rate for the
10-year reassessment was 57% (n = 219). The corre-
sponding figures for the sample without baseline respi-
ratory abnormalities (n = 199) were 82% and 64%
(n = 127) and for the subjects from the reference
group in the original DIMCA study (n = 402) 73%
and 46% (n = 186), respectively. Over the 10 years ob-
servation period, we found no indications for selective
dropout in either of these samples compared to the
initial DIMCA cohort.
Finally, a total of 532 subjects could be reassessed
and their test results sent to the chest physicians
for diagnostic assessment. Mean age was 43.8 (SD
10.4) years at baseline and 54.9 (SD 10.6) years at the
time of the reassessment for the current study (fur-
ther referred to as ‘Year 10’). Table 1 shows the char-
acteristics of the study population, with subjects
classified according to the chest physicians’ diagnoses
at Year 10.
Diagnoses by chest physicians and FPs
The two chest physicians judged the respiratory status of
the 532 subjects. Overall, the chest physicians assigned
a respiratory diagnosis in 222 subjects (42%): 138 cases
with COPD and 84 cases with asthma. Of these 222 sub-
jects (patients), 103 had not paid a single visit for respi-
ratory health problems to their FP during the 10-year
observation period, accounting for an underpresentation
of chronic respiratory disease of 46%.
Among the 119 patients with at least one documented
respiratory FP visit, 82 (69%) had been labelled with
‘COPD’ (n = 26), ‘asthma’ (n = 22) or ‘suspect’ (i.e.
a ‘tentative diagnosis’, n = 34) by their FP (see Table
2). In 31 of these patients, there was a full agreement be-
tween the chest physicians’ and the FP’s diagnoses (19
patients with COPD, 12 with asthma). In 17 cases, the
FP involved had diagnosed COPD instead of asthma or
vice versa, while in 27 patients the FP had only docu-
mented a tentative diagnosis of ‘suspected’ chronic respi-
ratory disease. The FPs had not documented a diagnosis
in 44 subjects who—according to the chest physicians’ as-
sessment—had COPD or asthma, accounting for an
underdiagnosis of 37%.
Of the 310 subjects who were assessed by the chest
physicians to be in good respiratory health, 85 (27%)
had visited their practice visit for a respiratory health
problem at least once, and in 11 of them (13%) the
FP had documented a tentative diagnosis of COPD or
asthma.
Subject characteristics related to diagnostic outcome
Table 3 shows the associations between the chest
physicians’ diagnoses of COPD and respiratory symp-
toms, smoking behaviour, age, gender and practice
visit rate. Chronic cough (OR = 2.3), higher age
(OR > 1.0), smoking (OR = 2.0) and FP visits for re-
spiratory health problems (OR = 1.1) were related to
a diagnosis of COPD.
Subjects with at least one documented respiratory
family practice visit for respiratory health problems
differed from the total group of COPD patients in
their pattern of respiratory symptoms. In these pa-
tients, chronic phlegm (OR = 10.6–12.0) was related
to a diagnosis of COPD.
From the perspective of the family practices, analy-
sis on the diagnostic outcome showed that wheeze
with breathlessness [OR = 5.5, 95% confidence inter-
val (CI) 2.0–15.2, adjusted for age, gender and smok-
ing behaviour] in combination with more practice
visits for respiratory health problems (OR = 1.8, 95%
CI 1.4–2.2) were related to a FP diagnosis of COPD
or asthma. More specific, previous practice visits for
respiratory health problems (OR = 1.2, 95% CI
1.1–1.4) and higher age (OR = 1.1, 95% CI 1.1–1.20)
were associated with a FP diagnosis of COPD,
whereas younger age (OR < 1.0, 95% CI 0.9 to <1.0),
TABLE 1 Characteristics of the study sample at Year 10 (figures are
proportions, unless stated otherwise)
Chest physicians’ diagnostic
assessment at Year 10
No respiratory
disease
Chronic
respiratory disease
COPD Asthma
n (% of total) 310 (58) 138 (26) 84 (16)
Age (mean, SD) 54.4 (10.5) 57.8 (10.0) 52.0 (11.4)
Gender (% female) 56.1 44.2 59.5
Cougha 4.6 27.7 20.7
Phlegmb 2.0 16.2 3.6
Breathlessnessc 2.9 20.6 35.7
Practice visit rate
(mean, SD)
0.6 (1.6) 3.1 (6.4) 2.9 (4.7)
Current
smoking
18.3 39.0 17.9
Ever smoking 65.9 81.0 56.0
Pack-years
(mean, SD)
10.7 (14.1) 21.1 (19.5) 8.9 (14.4)
FEV1
d (mean, SD) 105.2 (14.1) 85.6 (16.7) 96.5 (14.5)
FEV1/VC
e
(mean, SD)
73.8 (8.2) 61.4 (6.9) 72.3 (5.4)
VC, vital capacity; FEV1 forced expiratory volume in 1 second.
aChronic cough in winter.
bChronic phlegm (at least 3 months/year).
cWheeze with or without breathlessness (in previous 12 months).
dPost-bronchodilator FEV1 as % of the predicted value.
ePost-bronchodilator FEV1/VC (%).
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non-smoking (OR = 0.1, 95% CI >0 to <1.0) and
wheeze with breathlessness (OR = 7.0, 95% CI
2.4–21.0) were associated with a FP diagnosis of
asthma. Furthermore, in case of tentative FP diagno-
ses of chronic respiratory disease, patients had fewer
practice visits for respiratory reasons than in cases
with a diagnosis of COPD or asthma documented in-
their medical record (mean 5.1 versus 9.1 visits;
P = 0.005).
Discussion
Ten years after inclusion of formerly undiagnosed sub-
jects, chest physicians diagnosed 26% of subjects as
having COPD, and 16% as having (late-onset) asthma.
Two-thirds of these patients were not diagnosed ac-
cording to their family practice medical record. The
main reason for this lack of a documented diagnosis
was underpresentation: 46% of patients had not even
once visited the FP for reasons of respiratory nature.
Underdiagnosis occurred in 37% of patients who had
visited their FP for respiratory reasons in the 10-year
timeframe. Furthermore, diagnostic outcome proved
to be related to different respiratory symptoms: chest
physician-diagnosed COPD patients were character-
ized by the presence of chronic cough, whereas FP-
diagnosed COPD patients indicated to suffer from
chronic phlegm. In our Dutch primary care setting, re-
peated practice visits and complaints of wheeze and
breathlessness appeared to have triggered the diagnos-
tic process. We can only speculate whether or not our
findings would also apply to other populations or
different health care systems.
In primary care, the ecology of medical care19 pro-
vides a framework for perceived, presented and diag-
nosed health problems, and thus offers a reference for
our findings of FPs’ diagnosis of obstructive airway
disease. Clearly, presentation of perceived respiratory
signs and/or symptoms by an individual is a prerequi-
site to achieve a ‘timely’ diagnosis,6 with the FP in
a central position in most health care systems. In our
study, with access to 10-year FP records, data on respi-
ratory signs and symptoms could be related to practice
visits and reflect diagnostic outcome in family practice.
The findings confirm the critical role of patients in pre-
senting their (respiratory) signs and symptoms. In this
TABLE 2 Concordance and discordance between chest physicians’
diagnostic assessment and FPs’ documented diagnoses, 10 years after
inclusion of undiagnosed subjects from family practice (figures in the
table are numbers of subjects)
Chest physician
diagnosis
Medical record in family practicea
No chronic
respiratory
disease
COPD Asthma Suspectb Total
No chronic
respiratory disease
74 1c 3c 7c 85
COPD 27d 19 10 14 70
Asthma 17d 7 12 13 49
Total 118 27 25 34 204
FP, family physician; CPOD, chronic obstructive pulmonary disease.
aSubjects who had not visited their FP for respiratory health problems
(n = 103), representing the ‘underpresentation’ of chronic respiratory
conditions in family practice, are not included in this table.
b‘Tentative diagnosis’, for instance based on regular FP-prescribed re-
spiratory medication, requested additional diagnostic tests by FP
(skin prick test, spirometry or peak flow, histamine challenge test,
prednisolone test) or description of respiratory signs/complaints in
medical record (e.g. ‘asthmatic reaction’, ‘bronchial hyperresponsive-
ness’, ‘allergic reaction/allergy’, ‘atopy’, ‘exacerbation’).
cConsidered as (potential) ‘overdiagnosis’.
dConsidered as ‘underdiagnosis’.
TABLE 3 Associations between respiratory symptoms and practice visit rate in COPD patients according to the chest physicians’ assessment (ORs
with 95% CIs from logistic regression analyses, adjusted for age, gender, pack-years at baseline and smoking behaviour during follow-up)
All subjects with COPD
according to the chest
physicians (n = 138)
Subset with >1 respiratory
FP visits (n = 70)
Subset with >1 respiratory
FP visits and FP diagnosis
of COPD (n = 19)
Respiratory symptoms
Chronic cougha 2.28 (1.13–4.60) 1.06 (0.39–2.89) 0.71 (0.11–4.57)
Chronic phlegmb 2.20 (0.81–5.94) 12.04 (2.12–68.41) 10.61 (1.35–83.60)
Breathlessnessc 0.92 (0.44–1.92) 1.09 (0.44–2.71) 0.47 (0.10–2.22)
Practice visit rate 1.10 (1.03–1.17) 1.10 (1.02–1.18) 1.09 (0.98–1.21)
Age 1.03 (1.01–1.05) 1.03 (1.01–1.07) —
Gender 1.55 (0.98–2.45) 1.95 (0.89–4.25) —
Smoking
Pack-years 1.03 (1.01–1.04) 1.04 (1.01–1.06) —
Smoking 2.02 (1.16–3.51) 1.77 (0.65–4.85) —
Ever smoking 0.96 (0.51–1.81) 0.82 (0.30–2.26) —
ORs printed bold are statistically significant. FP, family physician; CPOD, chronic obstructive pulmonary disease.
aIn the winter season.
bAt least 3 months/year.
cIn the past 12 months.
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context, the finding of underdiagnosis to be associated
with low respiratory practice visit rate is not surprising
as FPs will generally not consider a single presentation
of respiratory symptoms to be a marker of chronic re-
spiratory disease. Previous reports have shown that
patients with shortness of breath only visited their FP
once the quality of every day life became compro-
mised or once they experienced variability in lung
function.20 However, our current results show that
some patients had not been diagnosed even after re-
peated practice visits. In this respect, the observed as-
sociations between respiratory symptoms and FPs’
diagnoses are relevant. It appears that FPs were
mainly alerted by wheeze with breathlessness rather
than chronic cough and phlegm. This should be taken
into account when implementing diagnostic guidelines
for chronic respiratory conditions, as signs and symp-
toms will trigger spirometry for further or final diag-
nostic assessment. This is particularly relevant in
patients with chronic cough who visit their FP only
a single time or infrequently.
Underdiagnosis of COPD still appears to be com-
mon, and a wide range of estimates has been pre-
sented. In a recent review study, which included both
population-based and clinical studies, prevalence esti-
mates for undiagnosed airway obstruction (including
COPD and asthma) ranged from 3% to 12%.21 Popu-
lation-based studies from Sweden,22 Korea23 and
Greece24 produced estimates in the same range. In
the early detection stage of the DIMCA study, the
overall prevalence of undiagnosed COPD and asthma
was 7.7%.10 In studies carried out among high-risk
groups in family practice settings, up to 22% undiag-
nosed COPD was observed.25–27 In a population-based
Swedish study, presenting a COPD prevalence of 12%,
only a minority (23%) had a physician diagnosis of
chronic bronchitis or emphysema,28 indicating a large
underdiagnosis. In our study, FPs’ underdiagnosis
(37%) solely refers to patients with former practice
visits for respiratory health problems, not to those
who had never consulted their FP with respiratory
symptoms.
Although presentation of symptoms is essential for
any reduction of underdiagnosis, the distinction be-
tween COPD and asthma is another aspect the FP has
to deal with. In the primary care setting, where a limited
set of diagnostic tools is available, the overlap of respi-
ratory symptoms in the two disease entities often gener-
ates a classification problem. This is illustrated by our
observation that about a quarter of the patients were di-
agnosed (and treated accordingly) with COPD instead
of asthma or vice versa. The fact that in a third of the
patients no final distinction in asthma or COPD had
been made by the FP might be explained by the step-
wise approach to diagnosis in family practice, where
observations over time in patients with suspicious
symptoms are often part of the diagnostic process.
Some comments should be made about the study set-
ting and the procedure for diagnosis. All study subjects
had participated in a study programme of early inter-
vention in COPD and, inevitably, the FPs had been in-
formed of the study progress for their patients. As
a consequence, the findings in the current study of FP-
diagnosed COPD might be an overestimation of the re-
ality in family practice. However, in our analysis of the
family practice medical records, we found that FP diag-
noses had only been made in response to patient-initi-
ated practice visits for respiratory symptoms. For
that reason, we believe that the influence of the pre-
vious DIMCA screening and monitoring programme
will have been limited and that our findings are rep-
resentative of diagnoses of COPD in family practice.
FP diagnoses were tracked from the patients’ records
over a period of 10 years, and occasionally a long pe-
riod of time had passed between this diagnosis and
the chest physicians’ assessment that served as the
reference diagnosis in our study. Further progression
of the disease and its signs and symptoms by the time
of the chest physicians’ assessment is therefore likely
to explain part of the underdiagnosis.
A second comment deals with the problem of differ-
entiating between COPD and asthma. In our diagnos-
tic decision tree (see Appendix Table 1), emphasis
was put on obstruction, only further down distinguish-
ing ‘signs of asthma’. As FPs will first focus on the
symptoms as presented by the patient, early-stage
COPD can easily be veiled by signs of asthma. There-
fore, FP ‘misdiagnosis’ of COPD can partly be ex-
plained by those patients who had a chest physician
diagnosis of ‘mild COPD with signs of asthma’.
In this study, which was performed within the con-
text of a population-based 10-year follow-up study in
formerly undiagnosed subjects from family practice,
the early development of respiratory disease was as-
sessed. After assessment of considerable underpresen-
tation and underdiagnosis of COPD in family practice,
and after showing a substantial increase of detection af-
ter multiple FP practice visits, we conclude that
a change in patients’ perception of respiratory health
problems and in FPs’ focus on the main indicator for
early-stage disease (i.e. chronic cough) may reduce
underdiagnosis of COPD. To facilitate patients’ earlier
presentation, health education is considered the main
tool to raise public awareness on the risk of underlying
COPD in case of chronic cough. On the primary care
level, stressing the importance of chronic cough and
phlegm in diagnostic guidelines could support timely
diagnosis of COPD in family practice and may reduce
the prevalence of undiagnosed COPD.
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